HCANYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31

HCA Healthcare, Inc.

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Jul 28, 2026

$454.88−3.96 (-0.86%)

Close on Oct 19, 2026

Market cap: $103.10B
P/E (TTM): 15.6
Dividend yield: 0.63%

HCA Healthcare, Inc. cash flow statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Depreciation & Amortization	3,523	3,312	3,077	2,969	2,853	2,721	2,596	2,278	2,131	1,966	1,904	1,820	1,753	1,679	1,465	1,421	1,425
Stock-Based Compensation	401	360	262	341	440	362	347	268	270	251	239	163	113	56	26	32	40
Deferred Income Taxes	310	22	229	571	-70	41	250	74	433	123	-160	-83	143	96	912	27	-520
Other Non-Cash Items	-195	-248	-189	-153	-99	-111	-129	-107	-83	-70	-54	-13	-7.00	-9.00	-8.00	-31	46
Change in Accounts Receivable	-94	-799	-935	-797	-962	327	-326	-423	-601	10	-4,114	-3,645	-4,395	-3,896	-3,248	-2,789	3,180
Change in Accounts Payable	666	359	604	-296	999	1,255	396	698	374	144	192	444	142	355	313	229	280
Operating Cash Flow	12,636	10,514	9,431	8,522	8,959	9,232	7,602	6,761	5,426	5,653	4,734	4,448	3,680	4,175	3,933	3,085	2,747
Capital Expenditures	-4,944	-4,875	-4,744	-4,395	-3,577	-2,835	-4,158	-3,573	-3,015	-2,760	-2,375	-2,176	-1,943	-1,862	-1,679	-1,325	-1,317
Divestitures	269	328	193	1,237	2,160	68	61	808	25	26	73	51	33	30	–	–	–
Other Investing Activities	12	-5.00	-19	-21	-4.00	-38	34	60	-4.00	6.00	7.00	10	9.00	11	5.00	10	1.00
Investing Cash Flow	-4,988	-4,933	-5,317	-3,389	-2,643	-3,393	-5,720	-3,901	-4,279	-3,240	-2,583	-2,918	-2,346	-2,063	-2,995	-1,039	-1,035
Dividends Paid	-679	-690	-661	-653	-624	-153	-550	-487	0	–	–	-7.00	-16	-3,148	-31	-4,257	–
Share Repurchases	-10,067	-6,042	-3,811	-7,000	-8,215	-441	-1,031	-1,530	-2,051	-2,751	-2,397	-1,750	-500	–	-1,503	–	–
Stock Issued	–	–	–	–	–	–	–	–	–	–	–	–	–	–	2,506	–	–
Debt Issued	8,474	7,495	3,224	5,997	4,344	2,700	6,451	2,000	1,502	5,400	5,548	5,502	–	4,850	5,500	2,912	2,979
Debt Repaid	-7,389	-2,410	-909	-2,830	-3,869	-3,437	-5,324	-1,704	-753	-4,475	-4,920	-5,164	-1,662	-2,441	-6,640	-2,268	-3,103
Other Financing Activities	-185	-277	-246	-212	-284	-205	-142	-248	-45	-98	188	109	-106	-67	48	-2.00	-6.00
Financing Cash Flow	-8,550	-4,582	-4,094	-5,656	-6,655	-4,677	-1,771	-3,075	-1,061	-2,508	-1,976	-1,378	-1,625	-1,780	-976	-1,947	-1,865
Foreign Exchange Rate Adjustments	9.00	-1.00	7.00	-20	-3.00	10	8.00	-15	0	–	–	–	–	–	–	–	–
Net Change in Cash	-893	998	27	-543	-342	1,172	119	-230	86	-95	175	152	-291	332	-38	99	-153
Free Cash Flow	7,692	5,639	4,687	4,127	5,382	6,397	3,444	3,188	2,411	2,893	2,359	2,272	1,737	2,313	2,254	1,760	1,430
Income Taxes Paid	1,740	1,844	1,386	1,175	2,182	1,002	849	872	1,205	1,255	1,186	1,057	694	618	-256	517	1,147
Interest Paid	2,207	1,938	1,892	1,662	1,502	1,607	1,914	1,744	1,700	1,666	1,650	1,758	1,832	1,723	1,987	1,994	1,751

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Mar 31, 2026

Profitability, TTM

Gross margin: –
Operating margin: –
Net margin: 8.9%
Return on equity, FY2025: -159.1%

Financial strength

Current ratio: 0.83
Debt to equity: -7.62
Debt to assets: 78.1%
Cash to current liabilities: 4.9%

Valuation

P/E ratio: 15.6
Price to sales: 1.35
Price to book: –
Dividend yield: 0.63%